Non-Alcoholic Fatty Liver Disease (NAFLD)  is becoming a health care concern due to the steady increase in its prevalence and its increased risk factor for diabetes and obesity. NAFLD is a liver condition closely associated with the metabolic syndrome. In its advanced stages, NAFLD may progress to liver inflammation (steatohepatitis) and if left unchecked may further lead to liver cirrhosis and cancer. In the US alone, the number of people affected with NAFLD is estimated to increase by 50% by 2030. Presently, there is no single effective treatment for NAFLD. Dietary and nutritional modifications used to address the underlying metabolic syndrome remain the choice for management of NAFLD.

Clinical trials have proven that Tocotrienol supplementation can protect the liver from NAFLD.
•            69% patients with improved liver imaging test results after Tocotrienol supplementation
•            50% patients had Lowered Model for end-stage liver disease (MELD) score with Tocotrienol Supplementation
•            57% patients improved and experience reduction of liver stiffness with Tocotrienol supplementation

DOWNLOAD TO LEARN MORE! >>>